XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes
(13)
Income Taxes

As a result of the IPO and the Transactions the Company owns a portion of the common units of the Operating Company, which is treated as a partnership for U.S. federal, and most applicable state and local income tax purposes. As a partnership, the Operating Company is generally not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by the Operating Company is passed through to and included in the taxable income or loss of its members in accordance with the terms of the Operating Agreement. The Company is subject to U.S. federal, state and local income taxes based on its share of the Operating Company’s pass-through taxable income.

The effective tax rate differs from the statutory tax rate primarily due to the Operating Company’s pass-through structure for U.S. income tax purposes.

For the year ended December 31, 2024, the Company did not have any unrecognized tax benefits as a result of tax positions taken during a prior period or during the current period. No interest or penalties have been recorded as a result of tax uncertainties.

Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future.

The following table details the Company’s provision for income taxes. Components of the provision for incomes taxes are as follows:

 

 

Year ended December 31,

 

(in thousands)

 

2024

 

 

2023

 

Current tax:

 

 

 

U.S. Federal

 

 

9

 

 

 

(61

)

U.S. State and local

 

 

15

 

 

 

(47

)

 

$

24

 

 

$

(108

)

 

 

 

 

 

 

 

Deferred tax:

 

 

 

 

 

 

U.S. Federal

 

 

(186

)

 

 

71

 

U.S. State and local

 

 

519

 

 

 

16

 

 

 

$

333

 

 

$

87

 

 

 

 

 

 

 

Valuation Allowance

 

 

 

 

 

 

Provision for income taxes

 

$

357

 

 

$

21

 

 

The company had an effective tax rate of 7.45% and 0.19% for the years ended December 31, 2024 and 2023, respectively. The reconciliation of the statutory federal income tax rate to the Company’s effective tax rate was as follows:

 

 

 

Year ended December 31,

 

 

 

2024

 

 

2023

 

Statutory U.S. federal income tax rate

 

 

21.00

%

 

 

21.00

%

State tax, net of federal benefits

 

 

0.51

%

 

 

0.22

%

FICA credits

 

 

 

 

 

 

Non-deductible expenses

 

 

0.05

%

 

 

0.02

%

Gain on GKBH remaining 50% interest

 

 

(2.02

)%

 

 

 

Non-controlling interest

 

 

(18.08

)%

 

 

(20.44

)%

Disallowed Exec Com - 162(m) limit

 

 

 

 

 

 

Valuation allowance

 

 

 

 

 

 

Tax Credits

 

 

(2.80

)%

 

 

(0.61

)%

State rate change

 

 

8.68

%

 

 

0.00

%

Return to provision

 

 

0.75

%

 

 

0.00

%

Cumulative book expense on unvested RSU

 

 

(0.91

)%

 

 

0.00

%

Other

 

 

0.27

%

 

 

0.00

%

Effective tax rate

 

 

7.45

%

 

 

0.19

%

The Company’s income tax expense varies from the expense that would be expected based on statutory rates due principally to income passed through to noncontrolling interests. Prior to the IPO, income taxes for GEN, LLC at the consolidated level were primarily state, and local minimum taxes. Subsequent to the IPO, the Company became a C Corporation subject to federal, state, and local income taxes with respect to its share of net taxable income of GEN, LLC.

Temporary differences and carryforward that give rise to deferred tax assets and liabilities are comprised of the following:

 

 

 

Year ended December 31,

 

(in thousands)

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

Net operating losses

$

-

 

$

-

 

Tax Credits

 

48

 

 

 

-

 

Outside basis differences

 

 

11,630

 

 

 

12,608

 

Charitable contributions carryover

 

 

-

 

 

 

-

 

State taxes

 

 

8

 

 

 

10

 

  Gross deferred tax asset before valuation

 

 

11,686

 

 

 

12,618

 

Net Deferred tax asset

 

$

11,686

 

 

$

12,618

 

 

 

 

 

 

 

Net Deferred tax assets

 

$

11,686

 

 

$

12,618

 

Tax Receivable Agreement (“TRA”)

GEN, Inc. entered into the TRA with the Operating Company and each of the members of the Operating Company (the “Members”) that provides for the payment by GEN Inc. to the Members of 85% of the amount of tax benefits, if any, that the Company may actually realize (or in some circumstances are deemed to realize) as a result of (i) increases in tax basis resulting from any future redemptions that are funded by GEN Inc. or exchanges of Class A Common Units described above in “Note 1—Organization and Description of Business” and (ii) certain other tax benefits attributable to payments made under the TRA.

The annual tax benefits are computed by calculating the income taxes due including such tax benefits, and the income taxes due without such benefits. The Operating Company expects to benefit from the remaining 15% of any tax benefits that it may actually realize. The TRA payments are not conditioned upon any continued ownership interest in the Operating Company. The rights of each noncontrolling interest holder under the TRA are assignable to transferees of its interest in the Operating Company. The timing and amount of aggregate payments due under the TRA may vary based on a number of factors, including the amount and timing of the taxable income the Operating Company generates each year and the applicable tax rate.

As of December 31, 2024, the Company had a liability related to its projected obligations under the TRA of $691 thousand, which reflect on the Company’s consolidated balance sheet in “Tax receivable agreement liability. As of December 31, 2023, the Company did not have a liability related to its projected obligations under the TRA. During the year ended December 31, 2024, and 2023, GEN Inc. did not make any payments to members of the Operating Company pursuant to the TRA.